The median length of treatment was four weeks, ranging from one to six weeks for recombinant tumour necrosis factor a and from one to nine weeks for recombinant interferon gamma. The median cumula-
tive doses achieved were 105 [ig (range 10-300) for recombinant tumour necrosis factor a and 1500 [ig (range for recombinant interferon gamma.
The toxicity associated with recombinapt tumour necrosis factor a was considerable and independent of dose. Six patients had severe rigors. One patient had a cardiovascular collapse with unrecordable blood pressure and pulse after an injection of 10 [ig into the lesion. He was resuscitated with intravenous fluids and steroids. A second patient, with cerebral metastases, developed severe rigors, which were followed by generalised convulsions. Treatment with recombinant tumour necrosis factor a was stopped in these two patients and continued with recombinant interferon gamma alone.
Important haematological, hepatic, or renal toxicity was not seen.
None of the subcutaneous lesions injected with recombinant tumour necrosis factor a regressed. One patient was injected twice into the lesion with both cytokines in combination, again with no response. Metastases advanced in more than one site in all patients.
Comment
The toxicity of recombinant tumour necrosis factor a was severe even at small doses. Feinberg et al reported irreversible cortical blindness in a patient with cerebral metastases from adenocarcinoma of the lung after its intravenous administration.5 They attributed this complication to cardiovascular toxicity rather than to toxicity to the central nervous system itself. Our results suggest, however, that the toxicity of recombinant tumour necrosis factor a might prohibit its use in the presence of cerebral metastases, which are particularly prevalent in patients with metastatic malignant melanoma.
We conclude that for the dosage and regimen used recombinant tumour necrosis factor cc combined with recombinant interferon gamma has no activity against this tumour and that the complications associated with the tumour necrosis factor are considerable. The figure shows the demand for such tests during the four years before and three years after the guidelines were introduced compared with the number ofpatients treated. The rates of increase were obtained from the slopes of the least square fit regression lines. For the three years after the intervention the rate (5 -92 tests/ month) was almost the same as that for the preceding four years (6-12 tests/month). The 95% confidence interval for the difference between the slopes was -2 07 to 2-41. As zero difference is near the middle of this interval there is no evidence that the slopes are different.2 Assuming that the existing circumstances continue, the previously intolerable rate of 700 tests a month will be reached within the year.
The correlation coefficient for the ratio of the numbers of tests to patients treated a month gave an RI value of 0-27 before and 0-01 after the intervention. Labour costs fell initially by 28%, but previous values were regained within months. Numbers of requests for haematology tests outside normal working hours and ofinpatients tr-eated each month duringfouryears before and three years after introduction ofguidelines to restrict demandfor out of hours haematology tests Comment These consistent rates of increase may be due to the increasing patient workload. Although our statistical analysis was based on crude data, the R2 values for the variables plotted indicate that between 55% and 65% of the variability in patient turnover and in tests can be attributed to a linear relation with time. We assume that the lack of correlation between the numbers of patients and requests result from the dilution of emergency cases with cold cases. Bed closures during the past three years may have altered this ratio. As there are no data linking an individual request with a particular patient the numbers of emergency cases in which haematology tests are required cannot be studied retrospectively.
Decisions about the future of the out of hours haematology service require precise and more detailed information, which should include the numbers of all types of haematology tests requested for each patient episode or admission. More data than recommended in the Korner report3 could be collected for this purpose, and local feedback and analysis would be useful. Our guidelines were designed to complement control by clinical audit or education and were expected to improve communication between clinical and laboratory staff. The previous availability of tests depended partly on the experience and compliance of the medical laboratory scientific officer.
The different strategies for reducing demand for tests have been described. The overall mean heights for the five cohorts increased uniformly from 175 5 cm to 179 8 cm. The table shows the main results. The increasing relative numbers attaining the studentereksamen reflected the expansion of higher education over the period. Analysis of variance for the intelligence test score showed a highly significant cohort effect (F 4,43969= 668-0, p<0001), a significant difference between the groups scoring above and below th& median (F 1,43969=1505,6, p<0001), and a significant interaction between groups and cohorts (F 4,43969=6 2, p<0001). Analysis of variance for the two educational levels also showed likewise a significant difference between the groups (F 1,30745=1168-5, p<0001) and a
